Leveraging Computational Modeling to Understand Infectious Diseases
We present advances in modeling techniques that have led to fundamental disease discoveries and impacted clinical translation.Recent FindingsCombining mechanistic models and machine learning algorithms has led to improvements in the treatment ofShigella and tuberculosis through the development of novel compounds. Modeling of the epidemic dynamics of malaria at the within-host and between-host level has afforded the development of more effective vaccination and antimalarial therapies. Similarly, in-host and host-host models have supported the development of new HIV treatment modalities and an improved understanding of the immune involvement in influenza. In addition, large-scale transmission models of SARS-CoV-2 have furthered the understanding of coronavirus disease and allowed for rapid policy implementations on travel restrictions and contract tracing apps.SummaryComputational modeling is now more than ever at the forefront of infectious disease research due to the COVID-19 pandemic. This review highlights how infectious diseases can be better understood by connecting scientists from medicine and molecular biology with those in computer science and applied mathematics.
A judge in California has ruled that state prison guards who work in and around facilities’ health care settings must be vaccinated against the coronavirus
As of the first week of October, 16 participants in the placebo group had gotten a symptomatic, lab-confirmed COVID-19 infection compared with just three who caught COVID in the vaccinated group.
White House press secretary Jen Psaki said President Biden's approval ratings are so low because people are "tired of fighting" the...
Rep. Glenn Thompson has tested positive for Covid-19, according to a statement released on Twitter, and is being treated at Walter Reed...
Rep. Glenn Thompson, R-Pa., has tested positive for the coronavirus and is currently receiving treatment at a hospital.
The Pfizer vaccine for kids ages 5-11 is 10 micrograms, roughly one third of the dose given to adolescents and adults.WebMD Health News
Dr. Laura Esserman answers the door of her bright yellow Victorian home in San Francisco’s Ashbury neighborhood with a phone at her ear. She’s wrapping up one of several meetings that day with her research team at University of California, San Francisco, where she heads the Carol Franc Buck Breast Care Center. She motions me in and reseats herself at a makeshift home office desk in her living room, sandwiched between a grand piano and set of enormous windows overlooking her front yard’s flower garden. It’s her remote base of operations when she’s not seeing patients or operating at the hospita...
The shots could begin in early November.
More News: Biology | Computers | Contracts | Coronavirus | COVID-19 | Epidemics | Epidemiology | Flu Pandemic | Infectious Diseases | Influenza | Influenza Vaccine | Laboratory Medicine | Learning | Malaria | Malaria Vaccine | Molecular Biology | Pandemics | SARS | Science | Tuberculosis | Universities & Medical Training | Vaccines